Next Article in Journal
Cranial Computer Tomography with Photon Counting and Energy-Integrated Detectors: Objective Comparison in the Same Patients
Next Article in Special Issue
Predicting Complete Cytoreduction with Preoperative [18F]FDG PET/CT in Patients with Ovarian Cancer: A Systematic Review and Meta-Analysis
Previous Article in Journal
Texture-Based Classification to Overcome Uncertainty between COVID-19 and Viral Pneumonia Using Machine Learning and Deep Learning Techniques
Previous Article in Special Issue
Histopathological Confirmed Polycythemia Vera with Transformation to Myelofibrosis Depicted on [18F]FDG PET/CT
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Interesting Images

Tuberculous Spondylodiscitis with Psoas Abscess Descending into the Anterior Femoral Compartment Identified Using 2-deoxy-2-[18F]fluoroglucose Positron Emission Tomography Computed Tomography

1
Orthopaedic Research Unit, Division of Orthopaedic Surgery, Department of Surgery, Faculty of Health Science, University of Cape Town, Cape Town 7925, South Africa
2
Department of Traumatology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland
3
General Medicine & Global Health Research Unit, Department of Medicine and Cape Heart Institute, Faculty of Health Science, University of Cape Town, Cape Town 7925, South Africa
4
CUBIC, PET/CT, Department of Medicine, University of Cape Town, Cape Town 7925, South Africa
5
Department of Internal Medicine, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland
*
Author to whom correspondence should be addressed.
Diagnostics 2024, 14(10), 1018; https://doi.org/10.3390/diagnostics14101018
Submission received: 23 April 2024 / Revised: 2 May 2024 / Accepted: 15 May 2024 / Published: 15 May 2024
(This article belongs to the Special Issue 18F-FDG PET/CT: Current and Future Clinical Applications)

Abstract

:
A 24-year-old immunocompetent woman underwent whole-body 18F-FDG PET/CT for the evaluation of MRI-suspicious tuberculous spinal lesions. The PET/CT results showed no pathological uptake in either lung, and there were no pathological changes on CT. There was increased uptake in the right psoas muscle, extending continuously down anterior to the right hip joint, posterior to and around the trochanteric region of the right femur, and into the right thigh, with an SUVmaxbw of 17.0. Subsequently, the patient underwent CT-guided biopsy as per protocol, which revealed drug-sensitive Mycobacterium tuberculosis, and the patient was started on standard tuberculosis treatment for 12 months.

Spinal tuberculosis usually results in local pain, neurological deficit, spinal instability and fever, and the duration from initial symptoms to adequate diagnosis can be up to several years [1,2,3]. Magnetic resonance imaging (MRI) has a reported specificity of 93% and a sensitivity of 94% in detecting spondylodiscitis and therefore is the current gold standard imaging modality for spinal TB [4]. If possible, an MRI of the whole spine should be performed to detect noncontinuous lesions, which occur in 15 to 20% of the patients [5]. PET/CT has recently been shown to be able to detect (extraspinal) sites of infection and monitor treatment success and has shown greater specificity in the diagnosis of spinal tuberculosis than MRI [6,7]. This case illustrates that PET/CT shows promise as a valuable imaging modality for the initial assessment of spinal tuberculosis and its extraspinal manifestation (Figure 1).

Author Contributions

J.S.: Patient recruitment, clinical patient evaluation, analysis, writing of the manuscript, PET/CT reading. T.K.: PET/CT reading, manuscript review. Z.M.: radiographer, manuscript review. A.L.: PET/CT reading, manuscript review. M.H.: manuscript review. F.T.: PET/CT reading, manuscript review. All authors have read and agreed to the published version of the manuscript.

Funding

The Spinal TB X project was supported by the AO Foundation, AO Spine (AOS-DIA-22-029-TRA). AO Spine is a clinical division of the AO Foundation, an independent medically-guided not-for-profit organization based in Davos, Switzerland. Prof. Friedrich Thienemann received support from the EDCTP2 program supported by the European Union (grant number RIA2017T- 2004-StatinTB). The General Medicine & Global Health Research Unit (www.gmgh.africa) of the University of Cape Town provided institutional support. Dr. Julian Scherer received personal funding from the University of Cape Town to pursue his Ph.D.

Institutional Review Board Statement

This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board (or Ethics Committee) of the University of Cape Town (HREC243/2022; 15 October 2022).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study. Written informed consent has been obtained from the patient to publish this paper.

Data Availability Statement

DICOM data are available from the corresponding author upon reasonable request.

Conflicts of Interest

None of the authors has a relationship with industry or financial disclosure related to the content of this manuscript.

References

  1. Flamm, E.S. Percivall Pott: An 18th century neurosurgeon. J. Neurosurg. 1992, 76, 319–326. [Google Scholar] [CrossRef] [PubMed]
  2. Batirel, A.; Erdem, H.; Sengoz, G.; Pehlivanoglu, F.; Ramosaco, E.; Gülsün, S.; Tekin, R.; Mete, B.; Balkan, I.; Sevgi, D.; et al. The course of spinal tuberculosis (Pott disease): Results of the multinational, multicentre Backbone-2 study. Clin. Microbiol. Infect. 2015, 21, 1008.e9–1008.e18. [Google Scholar] [CrossRef] [PubMed]
  3. Dunn, R.; Zondagh, I.; Candy, S. Spinal tuberculosis: Magnetic resonance imaging and neurological impairment. Spine 2011, 36, 469–473. [Google Scholar] [CrossRef] [PubMed]
  4. Shanmuganathan, R.; Ramachandran, K.; Shetty, A.P.; Kanna, R.M. Active tuberculosis of spine: Current updates. N. Am. Spine Soc. J. NASSJ 2023, 16, 100267. [Google Scholar] [CrossRef] [PubMed]
  5. Shetty, A.; Kanna, R.M.; Rajasekaran, S. TB spine—Current aspects on clinical presentation, diagnosis, and management options. Semin. Spine Surg. 2016, 28, 150–162. [Google Scholar] [CrossRef]
  6. Altini, C.; Lavelli, V.; Niccoli-Asabella, A.; Sardaro, A.; Branca, A.; Santo, G.; Ferrari, C.; Rubini, G. Comparison of the Diagnostic Value of MRI and Whole Body F-18-FDG PET/CT in Diagnosis of Spondylodiscitis. J. Clin. Med. 2020, 9, 1581. [Google Scholar] [CrossRef] [PubMed]
  7. Bassetti, M.; Merelli, M.; Di Gregorio, F.; Della Siega, P.; Screm, M.; Scarparo, C.; Righi, E. Higher fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) uptake in tuberculous compared to bacterial spondylodiscitis. Skelet. Radiol. 2017, 46, 777–783. [Google Scholar] [CrossRef] [PubMed]
Figure 1. A 24-year-old immunocompetent woman with a history of four months of lower back pain and magnetic resonance imaging (MRI) features suggestive of tuberculous spondylodiscitis of lumbar vertebra 2 and 3 was recruited to the Spinal TB X cohort at the Groote Schuur Hospital of the University of Cape Town (ClinicalTrials.gov Identifier: NCT05610098). As per study protocol, the patient underwent whole-body 2-deoxy-2-[18F]fluoroglucose (FDG) positron emission tomography (PET) computed tomography (PET/CT). PET/CT showed no pathological uptake in either lun’s and there were no pathological changes on CT (A). There was increased uptake in the right psoas muscle extending down anterior to the right hip joint, posterior to and around the trochanteric region of the right femur and into the right thigh, with an SUVmaxbw of 17.0 ((B,C) white triangles; (D,F,H,J) white arrows). On CT, the psoas muscle had an altered density, which spread caudally all the way into the lateral compartment of the thigh ((E,G,I,K), white arrows). Increased uptake was also seen in the left psoas muscle, with an SUVmaxbw of 8.04. A discrete 80 mm long by 40 mm wide psoas collection is noted on the left on CT ((E), orange arrow). In the L2–4 region, vertebral collapse with 50% destruction of L2 ((L,M), white arrow), significant body destruction of L3 ((L,M), orange arrow), and beginning erosion of the anterior body of L4 ((L,M), blue arrow), with an SUVmaxbw of 13, were noted. Subsequently, the patient underwent CT-guided biopsy as per protocol, which revealed drug-sensitive Mycobacterium tuberculosis, and the patient was started on standard tuberculosis treatment for 12 months.
Figure 1. A 24-year-old immunocompetent woman with a history of four months of lower back pain and magnetic resonance imaging (MRI) features suggestive of tuberculous spondylodiscitis of lumbar vertebra 2 and 3 was recruited to the Spinal TB X cohort at the Groote Schuur Hospital of the University of Cape Town (ClinicalTrials.gov Identifier: NCT05610098). As per study protocol, the patient underwent whole-body 2-deoxy-2-[18F]fluoroglucose (FDG) positron emission tomography (PET) computed tomography (PET/CT). PET/CT showed no pathological uptake in either lun’s and there were no pathological changes on CT (A). There was increased uptake in the right psoas muscle extending down anterior to the right hip joint, posterior to and around the trochanteric region of the right femur and into the right thigh, with an SUVmaxbw of 17.0 ((B,C) white triangles; (D,F,H,J) white arrows). On CT, the psoas muscle had an altered density, which spread caudally all the way into the lateral compartment of the thigh ((E,G,I,K), white arrows). Increased uptake was also seen in the left psoas muscle, with an SUVmaxbw of 8.04. A discrete 80 mm long by 40 mm wide psoas collection is noted on the left on CT ((E), orange arrow). In the L2–4 region, vertebral collapse with 50% destruction of L2 ((L,M), white arrow), significant body destruction of L3 ((L,M), orange arrow), and beginning erosion of the anterior body of L4 ((L,M), blue arrow), with an SUVmaxbw of 13, were noted. Subsequently, the patient underwent CT-guided biopsy as per protocol, which revealed drug-sensitive Mycobacterium tuberculosis, and the patient was started on standard tuberculosis treatment for 12 months.
Diagnostics 14 01018 g001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Scherer, J.; Kotze, T.; Mdiza, Z.; Lawson, A.; Held, M.; Thienemann, F. Tuberculous Spondylodiscitis with Psoas Abscess Descending into the Anterior Femoral Compartment Identified Using 2-deoxy-2-[18F]fluoroglucose Positron Emission Tomography Computed Tomography. Diagnostics 2024, 14, 1018. https://doi.org/10.3390/diagnostics14101018

AMA Style

Scherer J, Kotze T, Mdiza Z, Lawson A, Held M, Thienemann F. Tuberculous Spondylodiscitis with Psoas Abscess Descending into the Anterior Femoral Compartment Identified Using 2-deoxy-2-[18F]fluoroglucose Positron Emission Tomography Computed Tomography. Diagnostics. 2024; 14(10):1018. https://doi.org/10.3390/diagnostics14101018

Chicago/Turabian Style

Scherer, Julian, Tessa Kotze, Zintle Mdiza, Andrew Lawson, Michael Held, and Friedrich Thienemann. 2024. "Tuberculous Spondylodiscitis with Psoas Abscess Descending into the Anterior Femoral Compartment Identified Using 2-deoxy-2-[18F]fluoroglucose Positron Emission Tomography Computed Tomography" Diagnostics 14, no. 10: 1018. https://doi.org/10.3390/diagnostics14101018

APA Style

Scherer, J., Kotze, T., Mdiza, Z., Lawson, A., Held, M., & Thienemann, F. (2024). Tuberculous Spondylodiscitis with Psoas Abscess Descending into the Anterior Femoral Compartment Identified Using 2-deoxy-2-[18F]fluoroglucose Positron Emission Tomography Computed Tomography. Diagnostics, 14(10), 1018. https://doi.org/10.3390/diagnostics14101018

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop